TOKYO, Apr 22 (Reuters) – Japan plans to block purchases by foreign companies of domestically produced drugs and medical equipment to protect access to devices that have proven critical amid the coronavirus outbreak, a media outlet said on Wednesday. Communication.
The Japanese government will add companies that specialize in vaccines, drugs and advanced medical equipment to its list of businesses deemed critical to national security, the Nikkei financial daily said.
The move comes as Fujifilm Holdings Corp of Japan has gained worldwide attention for its flu drug Avigan, which is being tested as a treatment for COVID-19, the disease caused by the new coronavirus.
German government sources told Reuters last month that the US administration was investigating how it could gain access to a possible vaccine developed by the German firm, CureVac.
German authorities said they wanted to make sure that coronavirus vaccines were developed in Germany and Europe.
(Report by Ritsuko Ando; Edited by Andrew Heavens and Alex Richardson, edited in Spanish by Gabriela Donoso)